Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Murat Beyazyüz, Tarkan Küfeciler, Leyla Bulut, Cüneyt Ünsal, Yakup Albayrak, Esra Soydaş Akyol, Saliha Baykal, Murat Kuloglu & Kenji Hashimoto. (2016) Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study. Neuropsychiatric Disease and Treatment 12, pages 1261-1268.
Read now
Read now
Andrea T. U. Schaefers & Gertraud Teuchert-Noodt. (2016) Developmental neuroplasticity and the origin of neurodegenerative diseases. The World Journal of Biological Psychiatry 17:8, pages 587-599.
Read now
Read now
Gary Remington, Ofer Agid & George Foussias. (2011) Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment. Expert Review of Neurotherapeutics 11:4, pages 589-607.
Read now
Read now
Articles from other publishers (26)
Georges Jourdi, Samuel Fleury, Imane Boukhatem & Marie Lordkipanidzé. (2024) Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?. Neural Regeneration Research 19:3, pages 536-541.
Crossref
Crossref
Piotr Sikorski, Ewa Sikorska, Milena Michalska, Albert Stec, Kaja Kasarełło & Sylwia Fudalej. (2023) Neuroprotective factors in schizophrenia: BDNF, NGF, NT3, GDNF and their connection to the pathogenesis of schizophrenia. A narrative review. Current Problems of Psychiatry 24, pages 105-113.
Crossref
Crossref
Wassim Guidara, Meriam Messedi, Manel Naifar, Manel Maalej, Walid Khrouf, Sahar Grayaa, Mohamed Maalej, Dominique Bonnefont-Rousselot, Foudil Lamari & Fatma Ayadi. (2022) Plasma oxysterols in drug-free patients with schizophrenia. The Journal of Steroid Biochemistry and Molecular Biology 221, pages 106123.
Crossref
Crossref
Anna Haduch, Przemysław J. Danek, Wojciech Kuban, Renata Pukło, Natalia Alenina, Joanna Gołębiowska, Piotr Popik, Michael Bader & Władysława A. Daniel. (2022) Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats. Neurochemistry International 152, pages 105223.
Crossref
Crossref
Iman Sadeghi, Juan D. Gispert, Emilio Palumbo, Manuel Muñoz-Aguirre, Valentin Wucher, Valeria D'Argenio, Gabriel Santpere, Arcadi Navarro, Roderic Guigo & Natàlia Vilor-Tejedor. (2022) Brain transcriptomic profiling reveals common alterations across neurodegenerative and psychiatric disorders. Computational and Structural Biotechnology Journal 20, pages 4549-4561.
Crossref
Crossref
Piotr Czarny, Katarzyna Bialek, Sylwia Ziolkowska, Justyna Strycharz & Tomasz Sliwinski. (2019) DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?. Mutagenesis.
Crossref
Crossref
Joel Gruchot, David Kremer & Patrick Küry. (2019) Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses. Frontiers in Genetics 10.
Crossref
Crossref
Monalisa Jena, Rajeev Ranjan, Biswa Ranjan Mishra, Archana Mishra, Santanu Nath, Pallabi Sahu, Bikash Ranjan Meher, Anand Srinivasan & Rituparna Maiti. (2019) Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial. Journal of Psychiatric Research 112, pages 1-6.
Crossref
Crossref
Elisabetta Caletti & Francesca Siri. 2019. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches
259
276
.
Sung Woo Park, Mi Kyoung Seo, Roger S. McIntyre, Rodrigo B. Mansur, Yena Lee, Jae-Hon Lee, Seon-Cheol Park, Lyang Huh & Jung Goo Lee. (2018) Effects of olanzapine and haloperidol on mTORC1 signaling, dendritic outgrowth, and synaptic proteins in rat primary hippocampal neurons under toxic conditions. Neuroscience Letters 686, pages 59-66.
Crossref
Crossref
Mi Kyoung Seo, Young Hoon Kim, Roger S. McIntyre, Rodrigo B. Mansur, Yena Lee, Nicole E. Carmona, Ah Jeong Choi, Gyung-Mee Kim, Jung Goo Lee & Sung Woo Park. (2018) Effects of Antipsychotic Drugs on the Epigenetic Modification of Brain-Derived Neurotrophic Factor Gene Expression in the Hippocampi of Chronic Restraint Stress Rats. Neural Plasticity 2018, pages 1-10.
Crossref
Crossref
Axel Becker. 2017. In Vivo Neuropharmacology and Neurophysiology. In Vivo Neuropharmacology and Neurophysiology
369
388
.
Trevor Archer & Richard M. Kostrzewa. (2015) Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder. Neurotoxicity Research 28:3, pages 268-280.
Crossref
Crossref
Tobias Hornig, Lukas Sturm, Bernd Fiebich & Ludger Tebartz van Elst. (2015) Increased Blood-Reelin-Levels in First Episode Schizophrenia. PLOS ONE 10:8, pages e0134671.
Crossref
Crossref
M. Möller, T. Swanepoel & B. H. Harvey. (2015) Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development. ACS Chemical Neuroscience 6:7, pages 987-1016.
Crossref
Crossref
Trevor Archer, Serafino Ricci, Danilo Garcia & Max Rapp Ricciardi. (2014) Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders. Neurotoxicity Research 26:4, pages 400-413.
Crossref
Crossref
Roksana Zakharyan, Sofi Atshemyan, Anaida Gevorgyan & Anna Boyajyan. (2014) Nerve growth factor and its receptor in schizophrenia. BBA Clinical 1, pages 24-29.
Crossref
Crossref
Mark J. Millan, Kevin Fone, Thomas Steckler & William P. Horan. (2014) Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. European Neuropsychopharmacology 24:5, pages 645-692.
Crossref
Crossref
Renée N. Douville & Avindra Nath. 2014. Neurovirology. Neurovirology
465
485
.
Trevor Archer, Ulla Karilampi, Serafino Ricci & Max Rapp-Ricciardi. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
2181
2205
.
Urs Meyer. 2013. The Wiley‐Blackwell Handbook of Psychoneuroimmunology. The Wiley‐Blackwell Handbook of Psychoneuroimmunology
411
424
.
Nagahide Takahashi & Takeshi Sakurai. (2013) Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches. Neurobiology of Disease 53, pages 49-60.
Crossref
Crossref
Rachel E. Kneeland & S. Hossein Fatemi. (2013) Viral infection, inflammation and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 42, pages 35-48.
Crossref
Crossref
Urs Meyer. (2013) Developmental neuroinflammation and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 42, pages 20-34.
Crossref
Crossref
Isabelle Rapin & Samuel Robert Snodgrass. (2012) Classification issues in the developmental disorders: the case of autism and schizophrenia. Neuropsychiatry 2:5, pages 415-427.
Crossref
Crossref
Charlotte Emborg, Teresa Hallerbäck, Leif Jörgensen & Andreas Carlborg. (2012) A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark. Human Psychopharmacology: Clinical and Experimental 27:5, pages 492-498.
Crossref
Crossref